AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19852289 — intervention group
Group type: COMPARATOR
Intervention: Cyproterone (WM2)
Number of subjects: 100
Study 17885221 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment with early motion controlled in a removable orthosis, progressing to full weightbearing at 8 weeks.
Number of subjects: 0
Study 17885221 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical treatment with early motion controlled in a removable orthosis, progressing to full weightbearing at 8 weeks.
Number of subjects: 0
Study 15306665 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR plus the use of AEDs
Number of subjects: 19000
Study 15306665 — intervention group
Group type: COMPARATOR
Intervention: CPR only
Number of subjects: 19000
Study 11870120 — intervention group
Group type: EXPERIMENTAL
Intervention: K-soft 5000
Number of subjects: 1296
Study 11870120 — intervention group
Group type: COMPARATOR
Intervention: TDT set
Number of subjects: 1296
Study 9803702 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 128
Study 9803702 — intervention group
Group type: COMPARATOR
Intervention: 12-step facilitation (12SF)
Number of subjects: 128
Study 7697378 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulimia Nervosa (BN) patients
Number of subjects: 22
Study 7697378 — intervention group
Group type: EXPERIMENTAL
Intervention: Anorexia Nervosa (AN) patients
Number of subjects: 22
Study 7697378 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 22
Study 7697378 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 22
Study 28902112 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI)
Number of subjects: 16
Study 28902112 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 16
Study 30222505 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast Cancer Risk Assessment and Education (BreastCARE) intervention
Number of subjects: 1235
Study 30222505 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1235
Study 28035845 — intervention group
Group type: EXPERIMENTAL
Intervention: Superior peripheral iridotomy (LPI)
Number of subjects: 164
Study 28035845 — intervention group
Group type: COMPARATOR
Intervention: Inferior peripheral iridotomy (LPI)
Number of subjects: 164
Study 24915135 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon dioxide insufflation
Number of subjects: 200
Study 24915135 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 200
Study 24092940 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant lapatinib
Number of subjects: 455
Study 24092940 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant trastuzumab
Number of subjects: 455
Study 24092940 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of lapatinib and trastuzumab
Number of subjects: 455
Study 24092940 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F-FDG PET/CT metabolic response
Number of subjects: 455
Study 24092940 — intervention group
Group type: COMPARATOR
Intervention: (18)F-FDG PET/CT responders
Number of subjects: 455
Study 20937650 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified version of the Mother‐Infant Transaction Program
Number of subjects: 146
Study 20937650 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 146
Study 17661847 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART initiation
Number of subjects: 138
Study 17661847 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART interruption
Number of subjects: 138
Study 17661847 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART resumption
Number of subjects: 138
Study 17661847 — intervention group
Group type: EXPERIMENTAL
Intervention: Low baseline ferritin
Number of subjects: 138
Study 16366764 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (1.0, 2.0 mg/70 kg, oral)
Number of subjects: 24
Study 16366764 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine (0.3, 0.6 mg/70 kg, subcutaneous)
Number of subjects: 24
Study 16366764 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 11898005 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% tacrolimus ointment
Number of subjects: 570
Study 11898005 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% tacrolimus ointment
Number of subjects: 570
Study 11898005 — intervention group
Group type: COMPARATOR
Intervention: 0.1% hydrocortisone butyrate ointment
Number of subjects: 570
Study 9928964 — intervention group
Group type: EXPERIMENTAL
Intervention: Three counseling sessions designed to reduce further abuse
Number of subjects: 132
Study 9928964 — intervention group
Group type: COMPARATOR
Intervention: Wallet-sized cards listing community resources for abuse
Number of subjects: 132
Study 7495919 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention including biofeedback
Number of subjects: 0
Study 7495919 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 2125252 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheum E
Number of subjects: 30
Study 2125252 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 30
Study 2125252 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheum E + Captopril
Number of subjects: 30
Study 2125252 — intervention group
Group type: COMPARATOR
Intervention: Dietary therapy alone
Number of subjects: 30
Study 7297433 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml of magaldrate administered every two hours
Number of subjects: 9
Study 7297433 — intervention group
Group type: COMPARATOR
Intervention: 15 ml of magaldrate administered every three hours
Number of subjects: 9
Study 31050949 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + Laser (SRP + L)
Number of subjects: 38
Study 31050949 — intervention group
Group type: COMPARATOR
Intervention: Scaling and Root Planing (SRP)
Number of subjects: 38
Study 31050949 — intervention group
Group type: COMPARATOR
Intervention: SRP
Number of subjects: 38
Study 26547392 — intervention group
Group type: EXPERIMENTAL
Intervention: Jigsaw learning method
Number of subjects: 50
Study 26547392 — intervention group
Group type: COMPARATOR
Intervention: Lecture-based learning method
Number of subjects: 50
Study 26018225 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-motor dual-task training (DT)
Number of subjects: 27
Study 26018225 — intervention group
Group type: COMPARATOR
Intervention: Single-task training (ST)
Number of subjects: 27
Study 23896100 — intervention group
Group type: EXPERIMENTAL
Intervention: sipuleucel-T
Number of subjects: 176
Study 23896100 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 176
Study 21511709 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz stimulation during 10% MVC contraction
Number of subjects: 0
Study 21511709 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Hz stimulation during relaxed condition
Number of subjects: 0
Study 21511709 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz stimulation during relaxed condition
Number of subjects: 0
Study 21511709 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz stimulation during 5-10% MVC contraction
Number of subjects: 0
Study 21511709 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 Hz stimulation during 10% MVC contraction
Number of subjects: 0
Study 21511709 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Hz stimulation during 1-5% MVC contraction
Number of subjects: 0
Study 19631773 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound treatment
Number of subjects: 7
Study 19631773 — intervention group
Group type: COMPARATOR
Intervention: Control (no low-intensity pulsed ultrasound treatment)
Number of subjects: 7
Study 17355303 — intervention group
Group type: EXPERIMENTAL
Intervention: Vabra aspirator
Number of subjects: 147
Study 17355303 — intervention group
Group type: COMPARATOR
Intervention: Pipelle device
Number of subjects: 147
Study 16344342 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine, up to 3 mg/kg daily, individually adjusted according to blood lymphocyte number and the occurrence of adverse events.
Number of subjects: 14
Study 11949925 — intervention group
Group type: EXPERIMENTAL
Intervention: Handbook-only group received the Medicare & You 1999 handbook.
Number of subjects: 2107
Study 11949925 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulletin group received an abbreviated version of the handbook.
Number of subjects: 2107
Study 11949925 — intervention group
Group type: EXPERIMENTAL
Intervention: Handbook + CAHPS group received the Medicare & You handbook plus the CAHPS survey report.
Number of subjects: 2107
Study 11949925 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 2107
Study 9585822 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray
Number of subjects: 110
Study 9585822 — intervention group
Group type: COMPARATOR
Intervention: Ebastine tablets
Number of subjects: 110
Study 7707108 — intervention group
Group type: EXPERIMENTAL
Intervention: CMFVP (1 year of therapy with continuous cyclophosphamide, methotrexate, fluorouracil (5‐FU), vincristine, and prednisone)
Number of subjects: 531
Study 7707108 — intervention group
Group type: COMPARATOR
Intervention: FAC-M (20 weeks of therapy with four 5‐week courses of treatment with 5‐FU, doxorubicin, cyclophosphamide, and methotrexate)
Number of subjects: 531
Study 2576201 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 9
Study 2576201 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepindolol
Number of subjects: 9
Study 2576201 — intervention group
Group type: COMPARATOR
Intervention: Propranolol and Mepindolol
Number of subjects: 9
Study 58143 — intervention group
Group type: EXPERIMENTAL
Intervention: B.C.G. plus 5-fluorouracil (5-F.U.)
Number of subjects: 83
Study 58143 — intervention group
Group type: EXPERIMENTAL
Intervention: B.C.G. alone
Number of subjects: 83
Study 31804779 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) treatment
Number of subjects: 76
Study 31804779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 30898175 — intervention group
Group type: EXPERIMENTAL
Intervention: micellised vitamin D3 (DePura)
Number of subjects: 180
Study 30898175 — intervention group
Group type: COMPARATOR
Intervention: conventional vitamin D3 (Calcirol)
Number of subjects: 180
Study 28284745 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic Acid (ZA) for 4 years
Number of subjects: 170
Study 28284745 — intervention group
Group type: COMPARATOR
Intervention: Zoledronic Acid (ZA) for 2 years (Control)
Number of subjects: 170
Study 27088271 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping plus paracetamol
Number of subjects: 65
Study 27088271 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (control)
Number of subjects: 65
Study 23536124 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU)
Number of subjects: 998
Study 23536124 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 998
Study 22075964 — intervention group
Group type: EXPERIMENTAL
Intervention: non-psychiatric, indigenous label + lay help-seeking
Number of subjects: 160
Study 22075964 — intervention group
Group type: EXPERIMENTAL
Intervention: psychiatric diagnostic label + lay help-seeking
Number of subjects: 160
Study 22075964 — intervention group
Group type: EXPERIMENTAL
Intervention: prior contact in the non-psychiatric, indigenous label + lay help-seeking condition
Number of subjects: 160
Study 22075964 — intervention group
Group type: EXPERIMENTAL
Intervention: treated psychosis condition
Number of subjects: 160
Study 22075964 — intervention group
Group type: EXPERIMENTAL
Intervention: untreated psychosis condition
Number of subjects: 160
Study 19609048 — intervention group
Group type: EXPERIMENTAL
Intervention: Reopening of a totally occluded IRA (study group)
Number of subjects: 60
Study 19609048 — intervention group
Group type: COMPARATOR
Intervention: Partially occluded IRA (control group)
Number of subjects: 60
Study 17205319 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine 5 mg
Number of subjects: 20
Study 17205319 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone 1 mg
Number of subjects: 20
Study 17205319 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 3 mg
Number of subjects: 20
Study 17205319 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 16265986 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiao Yao Wan containing Chai Hu
Number of subjects: 58
Study 16265986 — intervention group
Group type: COMPARATOR
Intervention: Zhi Bai Di Huang Wan
Number of subjects: 58
Study 12125505 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide + albuterol (1 and 0.15 mg/kg, respectively)
Number of subjects: 20
Study 12125505 — intervention group
Group type: COMPARATOR
Intervention: Albuterol (0.15 mg/kg)
Number of subjects: 20
Study 10638174 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% isotretinoin gel
Number of subjects: 15
Study 10638174 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 8574256 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 micrograms ethinyl estradiol (EE) + 250 micrograms norgestimate (Cilest)
Number of subjects: 100
Study 8574256 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms EE + 150 micrograms desogestrel (Mercilon)
Number of subjects: 100
Study 8574256 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms EE + 150 micrograms desogestrel (Marvelon)
Number of subjects: 100
Study 8574256 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms EE + 75 micrograms gestodene (Femodene)
Number of subjects: 100
Study 2136041 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight fitting bikini type briefs
Number of subjects: 2
Study 2136041 — intervention group
Group type: COMPARATOR
Intervention: Loose fitting boxer type briefs
Number of subjects: 2
Study 537957 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg twice daily)
Number of subjects: 15
Study 30027768 — intervention group
Group type: EXPERIMENTAL
Intervention: i.d.EP + i.m.
Number of subjects: 100
Study 30027768 — intervention group
Group type: EXPERIMENTAL
Intervention: i.d. + i.m.EP
Number of subjects: 100
Study 30027768 — intervention group
Group type: EXPERIMENTAL
Intervention: i.d.EP + i.m.EP
Number of subjects: 100
Study 30027768 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 100
Study 26658119 — intervention group
Group type: EXPERIMENTAL
Intervention: Colostrum administration every 2 h for 46 h
Number of subjects: 12
Study 26658119 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 12
Study 24884888 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioural therapy (8 modules delivered online)
Number of subjects: 0
Study 22305246 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic Fields (PEMF)
Number of subjects: 18
Study 22305246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 20386309 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma interleukin‐8 levels > or =220 pg/mL
Number of subjects: 192
Study 20386309 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma interleukin‐8 cutoff <220 pg/mL
Number of subjects: 192
Study 20386309 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma interleukin‐8 cutoff <220 pg/mL in adults aged <40 yrs
Number of subjects: 192
Study 19030753 — intervention group
Group type: EXPERIMENTAL
Intervention: Peridural anesthesia with 0.75% ropivacaine
Number of subjects: 80
Study 19030753 — intervention group
Group type: EXPERIMENTAL
Intervention: Peridural anesthesia with 0.75% ropivacaine and 150 microg of clonidine
Number of subjects: 80
Study 19030753 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid anesthesia with 0.5% bupivacaine
Number of subjects: 80
Study 19030753 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid anesthesia with 0.5% bupivacaine and 50 microg of clonidine
Number of subjects: 80
Study 19030753 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study 15974218 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching gel with added amorphous calcium phosphate (ACP)
Number of subjects: 27
Study 15974218 — intervention group
Group type: COMPARATOR
Intervention: Control gel
Number of subjects: 27
Study 12675869 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial slow-flow pressure (SFpr = OP/MABP at Qb of 50 mL/min)
Number of subjects: 152
Study 12675869 — intervention group
Group type: EXPERIMENTAL
Intervention: SFpr monitoring
Number of subjects: 152
Study 12675869 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold of OP/MABP at Qb 0 (>0.53) and SFpr (>0.6)
Number of subjects: 152
Study 10232432 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary function tests during the acute phase of the disease (TL,COss and TL,COsb)
Number of subjects: 15
Study 10232432 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary function tests after a mean of 21 months
Number of subjects: 15
Study 10232432 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical recovery observation
Number of subjects: 15
Study 10232432 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrences of clinical signs
Number of subjects: 15
Study 10232432 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary function abnormalities
Number of subjects: 15
Study 8908436 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin ophthalmic solution 0.3%
Number of subjects: 131
Study 8908436 — intervention group
Group type: COMPARATOR
Intervention: Norfloxacin ophthalmic solution 0.3%
Number of subjects: 131
Study 1827418 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.020 mg ethynilestradiol + 0.150 mg desogestrel (Mercilon)
Number of subjects: 852
Study 1827418 — intervention group
Group type: COMPARATOR
Intervention: 0.030 mg ethynilestradiol + 0.150 mg desogestrel (Marvelon)
Number of subjects: 852
Study 1827418 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.020 mg ethynilestradiol (Mercilon)
Number of subjects: 852
Study 1827418 — intervention group
Group type: COMPARATOR
Intervention: 0.030 mg ethynilestradiol (Marvelon)
Number of subjects: 852
Study 1827418 — intervention group
Group type: EXPERIMENTAL
Intervention: Both preparations
Number of subjects: 852
Study 6345174 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent high-dose melphalan/prednisone (MP)
Number of subjects: 219
Study 6345174 — intervention group
Group type: COMPARATOR
Intervention: Continuous low-dose melphalan (M)
Number of subjects: 219
Study 30608426 — intervention group
Group type: EXPERIMENTAL
Intervention: aPDT (antimicrobial photodynamic therapy)
Number of subjects: 0
Study 30608426 — intervention group
Group type: COMPARATOR
Intervention: Scraper
Number of subjects: 0
Study 30608426 — intervention group
Group type: EXPERIMENTAL
Intervention: aPDT and Scraper
Number of subjects: 0
Study 30366229 — intervention group
Group type: EXPERIMENTAL
Intervention: $0 cash incentive for visiting a PCP
Number of subjects: 0
Study 30366229 — intervention group
Group type: EXPERIMENTAL
Intervention: $25 cash incentive for visiting a PCP
Number of subjects: 0
Study 30366229 — intervention group
Group type: EXPERIMENTAL
Intervention: $50 cash incentive for visiting a PCP
Number of subjects: 0
Study 30366229 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 0
Study 27927248 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipoint Pacing (MPP) using two LV pacing vectors
Number of subjects: 50
Study 27927248 — intervention group
Group type: COMPARATOR
Intervention: Standard ICD
Number of subjects: 50
Study 24502839 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Capacity Evaluation (FCE)
Number of subjects: 203
Study 24502839 — intervention group
Group type: COMPARATOR
Intervention: Semistructured functional interview (Control)
Number of subjects: 203
Study 22421863 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg
Number of subjects: 3
Study 22421863 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 400 mg
Number of subjects: 3
Study 19793416 — intervention group
Group type: EXPERIMENTAL
Intervention: Columellar strut
Number of subjects: 93
Study 19793416 — intervention group
Group type: COMPARATOR
Intervention: No columellar strut (Control)
Number of subjects: 93
Study 17605095 — intervention group
Group type: EXPERIMENTAL
Intervention: AF Suppression algorithm ON (treatment group)
Number of subjects: 411
Study 17605095 — intervention group
Group type: COMPARATOR
Intervention: AF Suppression algorithm OFF (control group)
Number of subjects: 411
Study 16167247 — intervention group
Group type: EXPERIMENTAL
Intervention: Sigmoid coloplasty
Number of subjects: 68
Study 16167247 — intervention group
Group type: COMPARATOR
Intervention: Straight sigmoidorectostomy
Number of subjects: 68
Study 11918503 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care (EC) - clinical pharmacist collaborative care intervention
Number of subjects: 74
Study 11918503 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) - control group
Number of subjects: 74
Study 11918503 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care (EC)
Number of subjects: 74
Study 9719037 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-free, urea-containing chewing gum (20 mg urea/piece), 5 pieces/day
Number of subjects: 29
Study 9719037 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-free, non-urea-containing chewing gum, 5 pieces/day
Number of subjects: 29
Study 9719037 — intervention group
Group type: COMPARATOR
Intervention: No gum-chewing
Number of subjects: 29
Study 9719037 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-free, urea-containing chewing gum
Number of subjects: 29
Study 9719037 — intervention group
Group type: EXPERIMENTAL
Intervention: Both gum periods (urea and non-urea)
Number of subjects: 29
Study 9719037 — intervention group
Group type: EXPERIMENTAL
Intervention: All periods
Number of subjects: 29
Study 7898342 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise training (N = 29)
Number of subjects: 38
Study 7898342 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 9)
Number of subjects: 38
Study 3190800 — intervention group
Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) 200 micrograms/day for 6 days
Number of subjects: 102
Study 3190800 — intervention group
Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) 400 micrograms every day
Number of subjects: 102